Manufacture of pharmaceutical co-crystals using twin screw extrusion: A solvent-less and scalable process

Journal of Pharmaceutical Sciences

Volumn 99, Issue 4, 2010, Pages 1693-1696

  Medina, Cesar ^a   Daurio, Dominick ^a   Nagapudi, Karthik ^a   Alvarez Nunez, Fernando ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; OXALIC ACID; SOLVENT; SORBIC ACID;

ARTICLE; CRYSTAL; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG MANUFACTURE; PARTICLE SIZE; REPRODUCIBILITY; SCALE UP; SOLVATE; STOICHIOMETRY; TWIN SCREW EXTRUSION;

EID: 77949791492     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21942     Document Type: Article

References (19)

1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 46:3-26.
2. Desiraju GR. 2003. Crystal and co-crystal. Cryst Eng Comm 5:466-467.
3. Dunitz JD. 2003. Crystal and co-crystal. A second opinion. Cryst Eng Comm 5:506.
4. Bond AD. 2007. What is a co-crystal? Cryst Eng Comm 9:833-834.
5. Variankaval N, Wenslow R, Murry J, Hartman R, Helmy R, Kwong E, Clas S-D, Dalton C, Santos I. 2006. Preparation and solid-state characterization of nonstoichiometric cocrystals of a phosphodiesterase-IV inhibitor and L-tartaric acid. Cryst Growth Des 6:690-700.
6. Trask AV, Motherwell WDS, Jones W. 2006. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm 320:114-123.
7. Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee JM, Guzman HR, Almarsson O. 2003. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J Am Chem Soc 125:8456-8457.
8. Childs SL, Chyall LJ, Dunlap JT, Smolenskaya VN, Stahly BC, Stahly GP. 2004. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. J Am Chem Soc 126:13335-13342.
9. Chen AM, Ellison ME, Peresypkin A, Wenslow RM, Variankaval N, Savarin CG, Natishan TK, Mathre DJ, Dormer PG, Euler DH, Ball RG, Ye Z, Wang Y, Santos I. 2007. Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid. Chem Commun (Cambridge, UK) 419-421.
10. Tanaka K, Toda F. 2000. Solvent-free organic synthesis. Chem Rev (Washington, DC) 100: 1025-1074.
11. Trask AV, Motherwell WDS, Jones W. 2004. Solvent-drop grinding: Green polymorph control of cocrystallisation. Chem Commun (Cambridge, UK) 890-891.
12. Friscic T, Trask AV, Jones W, Motherwell WDS. 2006. Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. Angew Chem Int Ed 45: 7546-7550.
13. Rodriguez-Hornedo N, Nehm SJ, Seefeldt KF, Pagan-Torres Y, Falkiewicz CJ. 2006. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 3:362-367.
14. Nehm SJ, Rodriguez-Spong B, Rodriguez-Hornedo N. 2006. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des 6:592-600.
15. Chiarella RA, Davey RJ, Peterson ML. 2007. Making co-crystals - The utility of ternary phase diagrams. Cryst Growth Des 7:1223-1226.
16. Ainouz A, Authelin J-R, Billot P, Lieberman H. 2009. Modeling and prediction of cocrystal phase diagrams. Int J Pharm 374:82-89.
17. Sheikh AY, Abd. Rahim S, Hammond RB, Roberts KJ. 2009. Scalable solution cocrystallization: Case of carbamazepine-nicotinamide I. Cryst Eng Comm 11:501-509.
18. Trask AV, Motherwell WDS, Jones W. 2005. Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration. Cryst Growth Des 5:1013-1021.
19. Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R, Akrami A, Rose M, Surapaneni S, Bostick T, King A, Neervannan S, Ostovic D, Koparkar A. 2008. The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J Pharm Sci 97:3942-3956.